Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility.

Kalich-Philosoph L, Roness H, Carmely A, Fishel-Bartal M, Ligumsky H, Paglin S, Wolf I, Kanety H, Sredni B, Meirow D.

Sci Transl Med. 2013 May 15;5(185):185ra62. doi: 10.1126/scitranslmed.3005402.

2.

Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice.

Carmely A, Meirow D, Peretz A, Albeck M, Bartoov B, Sredni B.

Hum Reprod. 2009 Jun;24(6):1322-9. doi: 10.1093/humrep/den481. Epub 2009 Feb 24.

PMID:
19240057
3.

Does controlled ovarian stimulation prior to chemotherapy increase primordial follicle loss and diminish ovarian reserve? An animal study.

Maman E, Prokopis K, Levron J, Carmely A, Dor J, Meirow D.

Hum Reprod. 2009 Jan;24(1):206-10. doi: 10.1093/humrep/den337. Epub 2008 Oct 14.

PMID:
18854408
4.

The organotellurium compound ammonium trichloro(dioxoethylene-o,o')tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice.

Okun E, Dikshtein Y, Carmely A, Saida H, Frei G, Sela BA, Varshavsky L, Ofir A, Levy E, Albeck M, Sredni B.

FEBS J. 2007 Jun;274(12):3159-70. Epub 2007 May 22.

Supplemental Content

Loading ...
Support Center